New York · Anxiety

Anxiety relapse after stopping an SSRI: telling it apart and what to do

You felt well, you stopped your SSRI, and now anxiety is creeping back. Or is it discontinuation? The difference matters for what comes next.

Need help now? If you’re thinking about suicide or feel unsafe, call or text 988, or call 911.

Quick Answer

Anxiety relapse after stopping an SSRI means the original anxiety symptoms return, usually weeks or more after stopping. It's different from discontinuation symptoms, which start within days and often include dizziness, irritability and flu-like feelings. Slow, supervised tapers lower both risks, and relapse can usually be treated again.

Understanding anxiety Relapse After Stopping an SSRI

Many people stop an SSRI after a period of feeling well, which is a reasonable goal. But anxiety disorders can return, especially after a first episode that was severe, after several past episodes, or when stress rises again. Stopping too quickly also makes it harder to tell what’s happening, because discontinuation symptoms can feel a lot like anxiety. A planned approach protects the progress you’ve made. This guide is part of our anxiety care hub for New York adults.

NIMH advises not stopping an antidepressant without talking with a health care provider, since stopping suddenly can cause withdrawal-like symptoms. Discontinuation symptoms usually start within a few days of a dose reduction and can include dizziness, irritability, trouble sleeping, flu-like feelings and brief electric-shock sensations. Relapse tends to come later and looks like the anxiety you had before: persistent worry, panic attacks, avoidance or tension that doesn’t let up.

For New Yorkers who stop medication during a busy season, timing the taper around calmer months can lower the risk of a setback. The NYC Health Department‘s 2024 report on the mental health of New Yorkers estimated that about 1,243,000 adult New Yorkers, roughly 18%, have been diagnosed with anxiety. Secure video visits anywhere in New York can make it easier to start care without a commute or a long search.

Telling discontinuation symptoms vs relapse apart, tapering slowly, and knowing your early warning signs are the three keys to a safer stop.

Planning a taper

A good taper plan includes the size of each reduction, how long to stay at each step, what symptoms to watch for, and what to do if they appear. Some medications need slower tapers than others. Choosing a calm period in life, rather than a stressful one, improves the odds. Many people continue therapy during and after a taper, which adds protection. Writing the plan down helps you follow it.

Who may benefit from staying on medication longer

People who had severe anxiety, several past episodes, or relapse after previous attempts to stop may benefit from staying on medication longer. That’s a personal decision made with your clinician, weighing side effects, preferences and life circumstances. Staying on medication long term is a reasonable choice for many people. The decision can always be revisited.

The Bottom Line

Anxiety Relapse After Stopping an SSRI is common and treatable, and careful care can make daily life feel more manageable.

Frequently Asked Questions

How do I know if my anxiety is coming back after stopping an SSRI?

Relapse usually appears weeks or months after stopping, with the return of familiar symptoms like persistent worry, panic attacks, avoidance or constant tension. Discontinuation symptoms are different and usually start within days of a dose change, often with dizziness, irritability or flu-like feelings. Keeping notes on when symptoms started helps. Your clinician can help sort out which is happening. Reach out early rather than waiting.

What are SSRI discontinuation symptoms?

Discontinuation symptoms can include dizziness, irritability, anxiety, trouble sleeping, nausea, flu-like feelings and brief electric-shock sensations. They usually start within days of lowering or stopping a dose. They often ease within days to weeks, and slowing the taper usually helps. They're not a sign of addiction. Tell your prescriber if they occur.

Should I restart my SSRI if anxiety returns?

If relapse happens, restarting the medication that helped before is often effective, but the decision should be made with your clinician. They'll review your symptoms, triggers and history. Sometimes a different medication or added therapy makes sense. Don't restart at your old dose on your own, since the plan may differ. Many people respond well to returning to treatment.

How slowly should I taper an SSRI for anxiety?

Taper speed depends on the medication, your dose, how long you've taken it and how you respond. Many tapers take weeks, and some take months. Reductions are usually made step by step, with time to adjust between steps. The pace can be slowed if symptoms appear. Your prescriber will build a plan with you.

Can therapy help prevent anxiety relapse?

Yes, cognitive behavioral therapy skills can lower the risk of relapse and make returning symptoms easier to manage. Practicing skills during and after a taper helps. Booster sessions can be useful if early warning signs appear. Therapy also helps address stressors that trigger anxiety. Many people combine therapy with a gradual taper.

Can I get support for a taper or relapse by video in New York?

Yes, tapers and relapse care work well by secure video anywhere in New York, with extra check-ins during transitions. Prescription changes are sent electronically to your pharmacy. You can contact the office between visits if symptoms appear. You need to be physically in New York during each visit. Early contact usually leads to quicker adjustments.

Key Takeaways

Dr. Gabriella I. Farkas, MD PhD, close-up portrait
  • Discontinuation symptoms usually begin within days of lowering or stopping a dose.
  • Relapse usually appears weeks or later, with the return of original anxiety symptoms.
  • Gradual, supervised tapers lower the risk of both.
  • NIMH advises talking to a health care provider before stopping an antidepressant.

Anxiety Relapse After Stopping an SSRI at a glance

Discontinuation vs. relapse (general)
Discontinuation symptomsRelapse
TimingDays after a dose changeWeeks or months later
Common featuresDizziness, irritability, flu-like feelings, sensory changesReturn of worry, panic or avoidance
CourseOften eases in days to weeksPersists or builds
Usual responseSlow the taperReview and often restart treatment

Why timing matters

The timing of symptoms is the most useful clue. Symptoms that appear within days of a change, and ease when the dose is restored or the taper is slowed, point to discontinuation. Symptoms that build gradually weeks after stopping, and follow familiar patterns of worry or panic, point to relapse. Sometimes both happen. Your clinician can help sort it out, especially if you’ve kept notes on dates and symptoms.

If anxiety returns

If relapse happens, treatment usually works again, often with the same medication that helped before. Your clinician may also review what triggered the return, such as a stressful life change, and whether therapy skills could help prevent future episodes. Returning to treatment isn’t a failure. It reflects that anxiety can be a recurring condition, like many others. Our guides on switching medications and an anxiety plan between appointments cover related topics.

Relapse support for New York patients

Tapers and restarts can be managed by video, with extra check-ins during the transition. Visits run by secure video anywhere in New York, while you’re physically in the state. The practice is in-network with Aetna and Cigna; confirm your New York plan with the office, and see self-pay fees on the Good Faith Estimate page.

Early warning signs of anxiety relapse

Common early signs of relapse include trouble sleeping, more frequent worry, irritability, avoiding situations you’d been handling, and physical tension like a tight chest or stomach. Many people have a personal pattern that shows up first. Agreeing on your warning signs with your clinician, and what to do if they appear, lets you act early. Early action often means a smaller setback.

Using therapy skills

Cognitive behavioral therapy skills, like noticing anxious thoughts, gradual exposure and breathing techniques, remain useful after medication stops. Practicing them during a taper helps. Booster therapy sessions can help if symptoms start to return. Skills you’ve built are yours to keep. They make relapse less likely and easier to manage.

If you’d like help sorting this out, you can request an evaluation by secure video anywhere in New York.
Illustration of a human brain
Middle-aged adult talking with a mental health clinician during an appointment
An evaluation starts with your history: when symptoms began and what they're affecting.

Where to go from here

Right now, if you're not safe
Call or text 988, or call 911.
If you'd like an evaluation
See how scheduling and telehealth work on the new patient page.
If you want to keep reading
Return to Dr. Farkas's New York anxiety resources for more guides.

How We Reviewed This Page

Written by Steven Lockhart of Health Marketing Group and clinically reviewed by Gabriella I. Farkas, MD PhD, a board-certified psychiatrist. Clinical information comes from the sources listed below, and the page is reviewed every 180 days or when guidance changes.

What’s new: September 29, 2026. Page published.

References

  1. National Institute of Mental Health. Generalized Anxiety Disorder: What You Need to Know. https://www.nimh.nih.gov/health/publications/generalized-anxiety-disorder-gad
  2. National Institute of Mental Health. Anxiety Disorders. https://www.nimh.nih.gov/health/topics/anxiety-disorders
  3. NYC Health Department. The State of Mental Health of New Yorkers (2024). https://www.nyc.gov/assets/doh/downloads/pdf/mh/state-of-mental-health-new-yorkers.pdf
  4. 988 Suicide & Crisis Lifeline. https://988lifeline.org/
Medical Disclaimer This content is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Only an evaluation can tell you what is going on. Gabriella I. Farkas, MD PhD, is licensed in South Carolina and New York; patients must be physically located in one of those states during telehealth visits.
Vital Voice Online

Schedule a Consultation

Fill out the form below and we'll get back to you within 24 hours.

Request Sent!

We've received your request and will be in touch within 24 hours.

Something went wrong